Search research articles
Contact Us
Filters
Showing results (341-350 of 614) with videos related to
Page
of 62
Sort By:
Advances in Therapy
|
May 28, 2025
Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review
Christoph Wanner, Ming-Hui Zhao, Alpesh N Amin, et al.
AIDS (London, England)
|
December 12, 2013
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1
Alonso Heredia, Charles Davis, Mohammed N Amin, et al.
Journal of Racial and Ethnic Health Disparities
|
February 27, 2024
Racial and Ethnic Disparities in COVID-19 Treatments in the United States
Essy Mozaffari, Aastha Chandak, Alpesh N Amin, et al.
Neurocritical Care
|
November 5, 2020
Hyperoxemia and Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Rebecca A Reynolds, Shaunak N Amin, Sumeeth V Jonathan, et al.
Molecular Immunology
|
January 20, 2015
Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding
Mihai Nita-Lazar, Aditi Banerjee, Chiguang Feng, et al.
International Journal of Molecular Sciences
|
April 14, 2026
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Breast Cancer Research and Treatment
|
February 11, 2016
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin
Marcia R Campbell, Hui Zhang, Shabnam Ziaee, et al.
Science Translational Medicine
|
April 8, 2010
Resiliency and vulnerability in the HER2-HER3 tumorigenic driver
Dhara N Amin, Natalia Sergina, Deepika Ahuja, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Clinical Kidney Journal
|
June 24, 2026
Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial
James O Burton, María J Izquierdo, Cecilia Linde, et al.
Page
of 62
Search research articles
Search
Showing results (341-350 of 614) with videos related to
Sort By:
Page
of 62
Advances in Therapy
|
May 28, 2025
Guideline-Recommended Disease-Modifying Therapies for Patients with Cardiorenal Disease: A Call-to-Action Narrative Review
Christoph Wanner, Ming-Hui Zhao, Alpesh N Amin, et al.
AIDS (London, England)
|
December 12, 2013
Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1
Alonso Heredia, Charles Davis, Mohammed N Amin, et al.
Journal of Racial and Ethnic Health Disparities
|
February 27, 2024
Racial and Ethnic Disparities in COVID-19 Treatments in the United States
Essy Mozaffari, Aastha Chandak, Alpesh N Amin, et al.
Neurocritical Care
|
November 5, 2020
Hyperoxemia and Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage
Rebecca A Reynolds, Shaunak N Amin, Sumeeth V Jonathan, et al.
Molecular Immunology
|
January 20, 2015
Desialylation of airway epithelial cells during influenza virus infection enhances pneumococcal adhesion via galectin binding
Mihai Nita-Lazar, Aditi Banerjee, Chiguang Feng, et al.
International Journal of Molecular Sciences
|
April 14, 2026
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harboring Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Breast Cancer Research and Treatment
|
February 11, 2016
Effective treatment of HER2-amplified breast cancer by targeting HER3 and β1 integrin
Marcia R Campbell, Hui Zhang, Shabnam Ziaee, et al.
Science Translational Medicine
|
April 8, 2010
Resiliency and vulnerability in the HER2-HER3 tumorigenic driver
Dhara N Amin, Natalia Sergina, Deepika Ahuja, et al.
Biorxiv : the Preprint Server for Biology
|
November 24, 2025
Suppression of Glucosylceramide Synthase Reverses Drug Resistance in Cancer Cells Harbor Homozygous p53 Mutants
Md Saqline Mostaq, Mohammad N Amin, Amanda Raphael, et al.
Clinical Kidney Journal
|
June 24, 2026
Sodium zirconium cyclosilicate post hospital discharge to prevent hyperkalaemia: phase 4, randomized CONTINUITY trial
James O Burton, María J Izquierdo, Cecilia Linde, et al.
Page
of 62